
Hyenergy S.A.
Activities of head office and holding companies, excluding financial holding companies
Overview
Hyenergy is a company that invests in innovative technologies focused on the production of green hydrogen and e-methanol, which are essential for the energy transition. It specializes in plasma gasification technology for efficient hydrogen production from biomass, aiming for negative carbon emissions. Additionally, Hyenergy is developing a research and development center in Poland dedicated to chemical processes supported by plasma.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 501 days for 2018). All were audited by a statutory auditor.
- 2024not filed
- 202316/08/2024
- 202218/10/2023
- 202107/07/2022
- 202024/09/2021
- 201927/11/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 2.34
- High
- PLN 2.34
- Low
- PLN 2.32
- Volume
- 2.25K
- Avg. vol.
- 4.4K
- Market cap
- PLN 77.91M
- P/E ratio
- –
- EPS
- -PLN 0.95
- Shares outstanding
- 33.58M
- 52-week
- PLN 2.32 – 2.50
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLINNGN00015
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2025 | USD 18.58k | USD -118.03k | USD -118.03k |
| Q1 2025 | USD 18.58k | USD -67.55k | USD -67.55k |
| Q4 2024 | USD 773.24k | USD 732.90k | USD 728.14k |
| Q3 2024 | USD 15.79k | USD -81.68k | USD -81.68k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Results vs industry
News
Periodic report for Q2 2025, standalone and consolidated
Change of the publication date of the periodic report for Q2 2025
Correction of the Q1 2025 report
Change of the publication date of the periodic report for Q2 2025 with information on violation of Good Practices of NewConnect-listed companies
Change of the publication date of the periodic report for Q2 2025 with information on violation of Good Practices of NewConnect-listed companies
Appointment of the Company's President of the Management Board
Industry
Offer
- Technology investments
- Research and development
- Green hydrogen production
- Biomass gasification
- Methanol production
- Genetic diagnostics
Websites
The site is available in: Polish and English.
- hyenergy.oneOdkrycia naukowe i nowe technologie w biznesie – HyEnergyWordPress 7.1ElementorYoast SEONginx
Authorized Representatives
Manner of representation
Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to submit declarations of will on behalf of the company. If a one-person management board is appointed, effective representation of the company is exercised by the President of the Management Board.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Centrum Badań Dna sp. z o.o. | 164,910.86 USD | 100% | ||
Central Europe Genomics Center sp. z o.o. | 486.22 USD | 26.4706% |
Capital group
| Name | Ownership |
|---|---|
| 100% | |
| 100% | |
| 100% |
Bank accounts
Was a VAT taxpayer from 2022-03-01 to 2025-10-22.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
37 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Aug 29, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 29, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 29, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 29, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 29, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Innowacji I Wdrożeń Bio-Inwest sp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Alioth Trading sp. z o.o. | $899,579.37 | aliothgroup.pl | ||
| TEH Transfer sp. z o.o. | $863,338.30 | tehtransfer.pl | ||
| Maestro Investments sp. z o.o. | $721,473.48 | maestroinvestments.pl | ||
| Vilevo sp. z o.o. | $574,507.06 | vilevo.pl | ||
| European Solutions sp. z o.o. | $516,912.99 | europeansolutions.pl | ||
| Innotech4life sp. z o.o. | $488,597.55 | innotech4life.pl | ||
| Fidelio Biogas sp. z o.o. | $197,684.83 | fideliobiogas.pl | ||
| Natalab sp. z o.o. | $117,374.31 | natalab.eu | ||
| Blue Boson Tech S.A. | $116,147.15 | blueboson.eu |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-23 | Address change (Ul. Piotra Ściegiennego 20, 60-128, Poznań → Aleja Jana Pawła II 22, 00-133, Warszawa) | |
| 2024-10-23 | Share capital increase (620,108.10 PLN → 3,358,108.10 PLN) | |
| 2024-10-23 | Name change (Inno-Gene → Hyenergy) | |
| 2024-04-22 | Share capital increase (570,108.10 PLN → 620,108.10 PLN) | |
| 2021-02-12 | Address change (Poznań → Ul. Piotra Ściegiennego 20, 60-128, Poznań) |
FAQ
Last updated: 2026-03-23